1. 王俊 中国 北京大学 中国工程院院士 Individualized tumor-informed circulating tumor DNA analysis for postoperative monitoring of non-sma..
2. Diehn, Maximilian 美国 Stanford University School of Medicine 2021美国医学院院士 Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal
3. 王俊 中国 北京大学 中国工程院院士 Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performa..
4. 于金明 中国 山东第一医科大学 中国工程院院士 Postoperative ctDNA detection predicts relapse but has limited effects in guiding adjuvant therapy i..
5. 王俊 中国 北京大学 中国工程院院士 Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
6. 于金明 中国 山东第一医科大学 中国工程院院士 Feasibility and oncological outcomes of video-assisted thoracic surgery versus thoracotomy for patho..
7. Weichselbaum, Ralph R. 美国 The University of Chicago 1997美国医学院院士 The oligometastatic spectrum in the era of improved detection and modern systemic therapy
8. 陈列平 美国 Yale University 2021美国科学院院士 Quantitative tissue analysis and role of myeloid cells in non-small cell lung cancer
9. 王俊 中国 北京大学 中国工程院院士 Clinical characteristics and management of primary mediastinal cysts: Asingle-centerexperience
10. Mantovani, Alberto 意大利 Humanitas University 2024美国科学院外籍院士 Prognostic significance of tumor-associated macrophages: past, present and future
11. 王俊 中国 北京大学 中国工程院院士 The Video-Assisted Thoracic Surgery for Mediastinal Bronchogenic Cysts: A Single-Center Experience
12. Hiroshi,Date 日本 Kyoto University The impact of vascular division sequence and epithelial-mesenchymal transition status on postoperati..
13. Yasushi,Yatabe 日本 Aichi Cancer Center Rare but clinically important salivary gland-type tumor of the lung: A review
14. Jean-François,Emile 法国 Hopital Ambroise Pare, Boulogne-Billancourt Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibi..
15. Genichiro,Ishii 日本 National Cancer Center Hospital East Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epider..
16. 吴一龙 中国 广东省人民医院 Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer Patients After Radica..
17. Paul,Hofman 法国 CHU de Nice The use of minimal residual disease in thoracic oncology: Gaps between promises and the on-the-groun..
18. 吴一龙 中国 广东省人民医院 Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in res..
19. 任秀宝 中国 天津医科大学 主任医师 Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer
20. 宋勇 中国 东部战区总医院 Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer